Masafumi Shionyu

1.1k total citations
29 papers, 758 citations indexed

About

Masafumi Shionyu is a scholar working on Molecular Biology, Cell Biology and Pharmacology. According to data from OpenAlex, Masafumi Shionyu has authored 29 papers receiving a total of 758 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 6 papers in Cell Biology and 3 papers in Pharmacology. Recurrent topics in Masafumi Shionyu's work include RNA and protein synthesis mechanisms (9 papers), RNA Research and Splicing (7 papers) and Glycosylation and Glycoproteins Research (5 papers). Masafumi Shionyu is often cited by papers focused on RNA and protein synthesis mechanisms (9 papers), RNA Research and Splicing (7 papers) and Glycosylation and Glycoproteins Research (5 papers). Masafumi Shionyu collaborates with scholars based in Japan, Indonesia and China. Masafumi Shionyu's co-authors include Kei Yura, Hiroyuki Toh, Hideto Watanabe, Mitiko Gō, Koji Kimata, Tsuyoshi Shirai, Atsushi Hijikata, Katsuji Shimizu, Tamayuki Shinomura and Kazu Matsumoto and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Masafumi Shionyu

28 papers receiving 751 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masafumi Shionyu Japan 16 523 193 96 69 54 29 758
Byung Hak Ha United States 17 646 1.2× 214 1.1× 58 0.6× 57 0.8× 42 0.8× 37 868
Stéphane Mouilleron United Kingdom 22 822 1.6× 326 1.7× 88 0.9× 159 2.3× 53 1.0× 31 1.3k
Pengfei Fang China 19 821 1.6× 58 0.3× 60 0.6× 179 2.6× 70 1.3× 59 1.1k
Susanna Repo Finland 10 345 0.7× 63 0.3× 83 0.9× 37 0.5× 20 0.4× 14 567
Xiao‐Xia Shao China 20 759 1.5× 98 0.5× 48 0.5× 62 0.9× 71 1.3× 84 1.4k
W. Iwasaki Japan 12 583 1.1× 123 0.6× 44 0.5× 24 0.3× 35 0.6× 26 742
Virginia L. Rath United States 16 871 1.7× 126 0.7× 137 1.4× 239 3.5× 69 1.3× 23 1.2k
Brian P. Smart United States 12 491 0.9× 94 0.5× 82 0.9× 290 4.2× 35 0.6× 12 844
Hiroyuki Hanzawa Japan 17 736 1.4× 83 0.4× 45 0.5× 193 2.8× 35 0.6× 45 1.1k
Tsutomu Agatsuma Japan 16 767 1.5× 125 0.6× 30 0.3× 217 3.1× 65 1.2× 22 1.1k

Countries citing papers authored by Masafumi Shionyu

Since Specialization
Citations

This map shows the geographic impact of Masafumi Shionyu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masafumi Shionyu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masafumi Shionyu more than expected).

Fields of papers citing papers by Masafumi Shionyu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masafumi Shionyu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masafumi Shionyu. The network helps show where Masafumi Shionyu may publish in the future.

Co-authorship network of co-authors of Masafumi Shionyu

This figure shows the co-authorship network connecting the top 25 collaborators of Masafumi Shionyu. A scholar is included among the top collaborators of Masafumi Shionyu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masafumi Shionyu. Masafumi Shionyu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nomura, Kaoru, Shoko Mori, Kohki Fujikawa, et al.. (2022). Role of a bacterial glycolipid in Sec-independent membrane protein insertion. Scientific Reports. 12(1). 12231–12231. 8 indexed citations
2.
Hijikata, Atsushi, Masafumi Shionyu, Motonori Ota, et al.. (2021). Evaluating cepharanthine analogues as natural drugs against SARS‐CoV‐2. FEBS Open Bio. 12(1). 285–294. 28 indexed citations
3.
Hijikata, Atsushi, et al.. (2020). Knowledge‐based structural models of SARS‐CoV‐2 proteins and their complexes with potential drugs. FEBS Letters. 594(12). 1960–1973. 21 indexed citations
4.
Nakamae, Ikuko, Noriko Yoneda‐Kato, Tsumoru Morimoto, et al.. (2019). Pentagamavunon-1 (PGV-1) inhibits ROS metabolic enzymes and suppresses tumor cell growth by inducing M phase (prometaphase) arrest and cell senescence. Scientific Reports. 9(1). 14867–14867. 37 indexed citations
5.
Tanaka, Makoto, Masafumi Shionyu, Chihiro Watanabe, et al.. (2018). Ridaifen-F conjugated with cell-penetrating peptides inhibits intracellular proteasome activities and induces drug-resistant cell death. European Journal of Medicinal Chemistry. 146. 636–650. 7 indexed citations
6.
Hijikata, Atsushi, Toshiyuki Tsuji, Masafumi Shionyu, & Tsuyoshi Shirai. (2017). Decoding disease-causing mechanisms of missense mutations from supramolecular structures. Scientific Reports. 7(1). 8541–8541. 27 indexed citations
7.
Nomura, Kaoru, Yasushi Tanimoto, Fumio Hayashi, et al.. (2016). The Role of the Prod1 Membrane Anchor in Newt Limb Regeneration. Angewandte Chemie International Edition. 56(1). 270–274. 5 indexed citations
8.
Hasegawa, Makoto, Makoto Tanaka, Kenya Nakata, et al.. (2013). A novel tamoxifen derivative, ridaifen-F, is a nonpeptidic small-molecule proteasome inhibitor. European Journal of Medicinal Chemistry. 71. 290–305. 17 indexed citations
9.
Ito, Shigeaki, Takeshi Senoura, Jun Wasaki, et al.. (2013). Structure of Novel Enzyme in Mannan Biodegradation Process 4-O-β-d-Mannosyl-d-Glucose Phosphorylase MGP. Journal of Molecular Biology. 425(22). 4468–4478. 29 indexed citations
11.
Ogawa, Hiroyasu, Masafumi Shionyu, Nobuo Sugiura, et al.. (2010). Chondroitin Sulfate Synthase-2/Chondroitin Polymerizing Factor Has Two Variants with Distinct Function*. Journal of Biological Chemistry. 285(44). 34155–34167. 21 indexed citations
12.
Yura, Kei, et al.. (2009). RESOPS: A Database for Analyzing the Correspondence of RNA Editing Sites to Protein Three-Dimensional Structures. Plant and Cell Physiology. 50(11). 1865–1873. 16 indexed citations
13.
Hasegawa, Makoto, et al.. (2008). Affinity labeling of the proteasome by a belactosin A derived inhibitor. Bioorganic & Medicinal Chemistry Letters. 18(20). 5668–5671. 13 indexed citations
14.
Iida, Kei, et al.. (2008). Alternative Splicing at NAGNAG Acceptor Sites Shares Common Properties in Land Plants and Mammals. Molecular Biology and Evolution. 25(4). 709–718. 18 indexed citations
15.
Watanabe, Hiroki, Hiroki Watanabe, Masafumi Shionyu, et al.. (2007). Splicing Factor 3b Subunit 4 Binds BMPR-IA and Inhibits Osteochondral Cell Differentiation. Journal of Biological Chemistry. 282(28). 20728–20738. 41 indexed citations
16.
Yura, Kei, Masafumi Shionyu, Atsushi Hijikata, et al.. (2006). Alternative splicing in human transcriptome: Functional and structural influence on proteins. Gene. 380(2). 63–71. 52 indexed citations
17.
Matsumoto, Kazu, Masafumi Shionyu, Mitiko Gō, et al.. (2003). Distinct Interaction of Versican/PG-M with Hyaluronan and Link Protein. Journal of Biological Chemistry. 278(42). 41205–41212. 122 indexed citations
18.
Yada, Toshikazu, Masanori Gotoh, Takashi Sato, et al.. (2003). Chondroitin Sulfate Synthase-2. Journal of Biological Chemistry. 278(32). 30235–30247. 71 indexed citations
19.
Shionyu, Masafumi, Keníchi Takahashi, & Mitiko Gō. (2001). Variable Subunit Contact and Cooperativity of Hemoglobins. Journal of Molecular Evolution. 53(4-5). 416–429. 4 indexed citations
20.
Yura, Kei, et al.. (1999). Repetitive use of a phosphate-binding module in DNA polymerase ? , Oct-1 POU domain and phage repressors. Cellular and Molecular Life Sciences. 55(3). 472–486. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026